Age-related mechanisms of altered tendon structure and function
肌腱结构和功能改变的年龄相关机制
基本信息
- 批准号:10678395
- 负责人:
- 金额:$ 49.71万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-04-01 至 2028-03-31
- 项目状态:未结题
- 来源:
- 关键词:ATAC-seqAddressAgeAge MonthsAgingAnabolismApoptosisAttenuatedAutomobile DrivingCell CommunicationCell DeathCell DensityCell physiologyCellsCellularityCessation of lifeCuesDataDropsElderlyEnvironmentEpigenetic ProcessExtracellular MatrixFlexorGenomicsGoalsHealthHeterogeneityHistologicHomeostasisImpaired healingImpairmentInflammatoryInjuryLocomotionLongevityMechanicsModelingModificationMolecularMorphologyMusPathologyPathway interactionsPatternPeriodicityPhasePhenotypePhysiologicalPopulationProductionQuality of lifeRejuvenationRoleSpontaneous RuptureStructureTendon InjuriesTendon structureTestingTherapeuticTissuesage relatedagedc-myc Genescell agecell dedifferentiationefficacy evaluationexperiencefunctional plasticityfunctional restorationhealingimprovedjuvenile animalmiddle agenovel strategiesnovel therapeuticspluripotencypreservationpreventprogramsproteostasisreparative capacityresponsesingle-cell RNA sequencingskeletaltherapeutic development
项目摘要
During aging, tendons demonstrate substantial disruptions in homeostasis, leading to impairments in structure
and function. Given the central role of tendon in appropriate skeletal locomotion and ambulation, impaired
tendon function contributes to substantial declines in overall function and quality of life during aging. Moreover,
aged tendons are more likely to undergo spontaneous rupture, and the healing response following injury is
drastically impaired in aged tendons. Thus, there is a clear need to develop strategies to maintain tendon
homeostasis and healing capacity through the lifespan. Tendon cell density sharply declines by about 12
months of age in mice, and this low cell density is retained even in geriatric tendons. Our preliminary data
suggests that this decline in cellularity initiates a degenerative cascade due to insufficient production of the
extracellular matrix components needed to maintain tendon homeostasis. Thus, preventing this decline in
tendon cellularity has great potential for maintaining tendon health. In addition, the tenocytes that remain in
aged tendon demonstrate substantial alterations in their molecular programs, relative to young tendon cells.
Surprisingly, this programmatic skewing does not seem to drive additional homeostatic disruptions, but we
hypothesize that it is a key driver of age-related impairments in tendon healing. Thus, reversing this
programmatic skewing may restore physiological healing function to aged tendons. While the pathways that
drive aging-induced tendon cell death vs. programmatic skewing are likely distinct, epigenetic modifications
underly nearly every aspect of cell function. Indeed, partial epigenetic reprogramming has demonstrated
tremendous potential in addressing a range of age-related pathologies. In this proposal we will test the central
hypothesis that age-related tenocyte apoptosis driving tendon degeneration, and intrinsic programming shifts
leading to impaired healing capacity can be prevented via partial epigenetic reprogramming. In Aim 1 we will
define the multi-scale mechanisms of age-related tendon degeneration using a combination of genomics,
histological, and mechanical analyses. We will then determine the efficacy of partial reprogramming to maintain
tendon structure-function through the lifespan. In Aim 2 we will define how aging alters the cellular response to
tendon injury using a well-established model of healing in the flexor digitorum longus tendon. We will then
demonstrate that partial reprogramming can successfully restore the tenocyte functional plasticity that is
required for physiological healing. Successful completion of these studies will define the tendon aging
signature and establish partial reprogramming as a novel approach to maintain tendon health and healing
capacity through the lifespan.
在老化过程中,肌腱表现出体内平衡的实质性破坏,导致结构损伤
和功能鉴于肌腱在适当的骨骼运动和截肢中的核心作用,
肌腱功能在衰老过程中导致整体功能和生活质量的显著下降。此外,委员会认为,
老年肌腱更容易发生自发性断裂,损伤后的愈合反应是
老化的肌腱严重受损因此,有一个明确的需要,以制定战略,以保持肌腱
体内平衡和愈合能力。肌腱细胞密度急剧下降约12
月龄的小鼠中,这种低细胞密度甚至在老年肌腱中也保留。我们的初步数据
这表明,这种细胞结构的下降启动了一个退化级联,由于生产不足,
细胞外基质成分需要维持肌腱稳态。因此,防止这种下降,
肌腱细胞结构对于维持肌腱健康具有巨大潜力。此外,肌腱细胞仍然存在于
相对于年轻的肌腱细胞,老年肌腱在其分子程序中表现出实质性的改变。
令人惊讶的是,这种程序性的倾斜似乎并没有驱动额外的稳态破坏,但我们
假设它是肌腱愈合中与年龄相关的损伤的关键驱动因素。因此,扭转这一局面
程序性偏斜可以恢复老化肌腱的生理愈合功能。而那些
驱动器老化诱导的肌腱细胞死亡与程序倾斜可能是不同的,表观遗传修饰
几乎是细胞功能的各个方面的基础。事实上,部分表观遗传重编程已经证明,
在解决一系列与年龄有关的病理方面具有巨大潜力。在本建议中,我们将测试中央
假设年龄相关的腱细胞凋亡驱动肌腱变性和内在编程转移
可通过部分表观遗传重编程来预防导致愈合能力受损的疾病。在目标1中,
使用基因组学的组合来定义与年龄相关的肌腱退化的多尺度机制,
组织学和力学分析。然后,我们将确定部分重编程的有效性,以维持
肌腱的结构-功能。在目标2中,我们将定义衰老如何改变细胞反应,
肌腱损伤使用一个良好建立的愈合模型,在屈趾长肌腱。然后我们将
证明部分重编程可以成功地恢复肌腱细胞的功能可塑性,
生理愈合所需的。这些研究的成功完成将定义肌腱老化
签名并建立部分重编程作为维持肌腱健康和愈合新方法
通过寿命的能力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alayna Loiselle其他文献
Alayna Loiselle的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alayna Loiselle', 18)}}的其他基金
Modulating Cell-fate to Promote Regenerative Tendon Healing
调节细胞命运促进肌腱再生愈合
- 批准号:
10447794 - 财政年份:2021
- 资助金额:
$ 49.71万 - 项目类别:
Modulating Cell-fate to Promote Regenerative Tendon Healing
调节细胞命运促进肌腱再生愈合
- 批准号:
10208209 - 财政年份:2021
- 资助金额:
$ 49.71万 - 项目类别:
Modulating Cell-fate to Promote Regenerative Tendon Healing
调节细胞命运促进肌腱再生愈合
- 批准号:
10642773 - 财政年份:2021
- 资助金额:
$ 49.71万 - 项目类别:
s100a4 Signaling in Fibrotic Diabetic Tendon Healing
纤维化糖尿病肌腱愈合中的 s100a4 信号转导
- 批准号:
10360571 - 财政年份:2018
- 资助金额:
$ 49.71万 - 项目类别:
Defining the relationship between attenuated insulin receptor signaling and fibrosis in diabetic tendinopathy
确定糖尿病肌腱病中胰岛素受体信号减弱与纤维化之间的关系
- 批准号:
9108008 - 财政年份:2016
- 资助金额:
$ 49.71万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 49.71万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 49.71万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 49.71万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 49.71万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 49.71万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 49.71万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 49.71万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 49.71万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 49.71万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 49.71万 - 项目类别:
Research Grant














{{item.name}}会员




